You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ongentys

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Opicapone Treatment Initiation Open-Label Study

Active, not recruiting
  • Parkinson Disease
  • Los Gatos, California
  • +5 more
Apr 7, 2022

Opicapone Plus Standard of Care in Elderly Parkinson's Disease

Completed
  • Parkinson Disease
  • Norwich, Norfolk, United Kingdom
    Norfolk&Norwich University Hospitals
Oct 1, 2021

Parkinson Disease Trial in Leeds (Ongentys, BIA 9-1067 (test))

Completed
  • Parkinson Disease
  • Ongentys
  • BIA 9-1067 (test)
  • Leeds, United Kingdom
    Covance Clinical Research
Dec 30, 2020

Parkinson Disease Trial in Anyang-si (Ongentys 50mg, Madopar Tab. 125 or Perkin Tab. 25-100mg)

Recruiting
  • Parkinson Disease
  • Ongentys 50mg
  • Madopar Tab. 125 or Perkin Tab. 25-100mg
  • Anyang-si, Gyeonggi-do, Korea, Republic of
    Hallym University Sacred Heart Hospital
Jun 17, 2021

Parkinson Disease Trial in Merthyr Tydfil (50 mg BIA 9 1067, 25 mg BIA9 1067, 50 mg Ongentys)

Completed
  • Parkinson Disease
  • 50 mg BIA 9 1067
  • +3 more
  • Merthyr Tydfil, United Kingdom
    Simbec Research Ltd
Feb 10, 2020

Parkinson Disease Trial in Neu-Ulm (Opicapone (OPC))

Completed
  • Parkinson Disease
  • Opicapone (OPC)
  • Neu-Ulm, Germany
    Nuvisan GmbH
Oct 12, 2018

Parkinson's Disease With Wearing-off Motor Fluctuations Trial in Dresden (BIA 9-1067, levodopa/dopa decarboxylase inhibitor)

Completed
  • Parkinson's Disease With Wearing-off Motor Fluctuations
  • BIA 9-1067
  • levodopa/dopa decarboxylase inhibitor
  • Dresden, Germany
    University Hospital Carl Gustav Carus at the TU Dresden, Neurolo
Oct 12, 2018

Parkinson Disease Trial (Opicapone (OPC))

Completed
  • Parkinson Disease
  • Opicapone (OPC)
  • (no location specified)
Apr 12, 2017